The therapeutic potential of VEGF inhibition in diabetic microvascular complications

scientific article published on January 2007

The therapeutic potential of VEGF inhibition in diabetic microvascular complications is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P6179Dimensions Publication ID1021728303
P356DOI10.2165/00129784-200707060-00002
P698PubMed publication ID18076206

P2093author name stringGianpaolo Zerbini
Gemma Tremolada
Rosangela Lattanzio
Gabriella Mazzolari
P2860cites workIncreased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathyQ34324536
Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3.Q36796674
P433issue6
P921main subjectmicrovesselQ6840468
P304page(s)393-398
P577publication date2007-01-01
P1433published inAmerican journal of cardiovascular drugsQ2555367
P1476titleThe therapeutic potential of VEGF inhibition in diabetic microvascular complications
P478volume7

Reverse relations

cites work (P2860)
Q91900851Advanced Glycation End-Products and Hyperglycemia Increase Angiopoietin-2 Production by Impairing Angiopoietin-1-Tie-2 System
Q34370502Chromosome 2q31.1 associates with ESRD in women with type 1 diabetes
Q35124660Circulating angiopoietin-2 and soluble Tie-2 in type 2 diabetes mellitus: a cross-sectional study
Q51283955Circulating angiopoietin-2 levels in children and adolescents with type 1 diabetes mellitus: relation to carotid and aortic intima-media thickness.
Q37638770Differential systemic gene expression profile in patients with diabetic macular edema: responders versus nonresponders to standard treatment
Q36261867Effect of fosinopril on chemerin and VEGF expression in diabetic nephropathy rats
Q32177710Ethnic differences in the +405 and -460 vascular endothelial growth factor polymorphisms and peripheral neuropathy in patients with diabetes residing in a North London, community in the United Kingdom.
Q38527798Identifying Common Genetic Risk Factors of Diabetic Neuropathies
Q42324836Propyl gallate plays a nephroprotective role in early stage of diabetic nephropathy associated with suppression of glomerular endothelial cell proliferation and angiogenesis
Q34466706Relationship between single nucleotide polymorphisms in the 3'-untranslated region of the vascular endothelial growth factor gene and susceptibility to diabetic peripheral neuropathy in China
Q43176459Vascular endothelial growth factor expression levels of gingiva in gingivitis and periodontitis patients with/without diabetes mellitus
Q37400759Vascular endothelial growth factor inhibition by dRK6 causes endothelial apoptosis, fibrosis, and inflammation in the heart via the Akt/eNOS axis in db/db mice
Q38174892Vascular endothelial growth factor trap-eye (Aflibercept) for the management of diabetic macular edema

Search more.